Loading
Total declarations
Companies
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Latest filing published 01 Oct 2026 for SPAR Group, Inc.. Read the official filing
Filing timeline
BuySaleJohn B. Bode
Insider track record
Disclosed buys
5
Disclosed sells
0
Signal history
Closed purchases
Market purchases
5
Positive at T+90
100%
Median T+90
+5.9%
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +1.8%Entry US$9.51 · Close at T+90 US$9.68
- +14.7%Entry US$8.21 · Close at T+365 US$9.42
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
John B. Bode: trading record in brief
John B. Bode (board member) discloses dealings in 4 companies, chiefly Zevra Therapeutics, Inc., FISION Corp and Newton Golf Company, Inc. In total, 9 filings cover trades dated from 31 May 2021 to 29 September 2026.
On the market, this insider has only ever bought: 5 purchases, €220k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 3 share grants and 1 option exercise.
A typical purchase (the median) is worth €48k. 2 out of 5 purchases came within 30 days of a purchase by at least one other insider of the same company. Purchases made close together by different insiders form what is called a cluster.
The newest entry dates from 1 October 2026: a share grant, in SPAR Group, Inc. The most recent open-market purchase was published on 20 August 2025, 424 days ago. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to John B. Bode
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
110,000 sharesCommon StockSEC:0001437749-26-031787:0
39,200 shares@ US$4.9743.2% of flowCommon StockSEC:0001612084-26-000002:0
18,549 shares0Common StockSEC:0001493152-26-004958:0
5,000 shares@ US$9.16510.1% of flowCommon StockSEC:0001437749-25-027456:0
Canonical exit: 17 Nov 2025 (T+90)
10,000 shares@ US$7.962418.7% of flowCommon StockSEC:0001437749-25-008738:0
Canonical exit: 17 Jun 2025 (T+90)
10,000 shares@ US$5.866113.9% of flowCommon StockSEC:0001437749-24-022734:0
Canonical exit: 10 Oct 2024 (T+90)
10,000 shares@ US$5.133312.3% of flowCommon StockSEC:0001437749-23-025313:0
Canonical exit: 4 Dec 2023 (T+90)
1,390 shares@ US$5.0351.7% of flowCommon StockSEC:0001437749-23-015335:0
Canonical exit: 16 Aug 2023 (T+90)
396,825 shares@ US$0.0315100.0% of flowCommon StockSEC:0001612084-21-000003:0
9 of 9 declarations
